Inhaled anticholinergic agents, such as ipratropium, oxitropium, and tiotropium also increase luminal diameter by smooth muscle relaxation and decreased submucosal gland mucin secretion in COPD patients47. Here, MUC5AC is linked to chronic obstructive pulmonary disease.